Literature DB >> 28194476

[Diagnosis and treatment of chronic kidney disease].

M Girndt1.   

Abstract

Chronic kidney disease is defined by decreased glomerular filtration rate or proteinuria. Diabetic nephropathy and hypertensive renal damage are responsible for the majority of cases. The initiation of therapy has to consider if causal treatment of the underlying disease is possible and indicated. In all patients, even if specific treatment is not possible, therapy should aim at reducing progression of kidney failure. Chronic kidney diseases tend to intrinsic deterioration that persists after cessation of the causative damaging pathomechanism. Progression of disease can be delayed; the most important measures include strict blood pressure control, reduction of proteinuria, and avoidance of further renal harm. Kidney disease induces typical sequelae such as left ventricular hypertrophy, vascular calcification, anemia, and renal osteodystrophy. While these are well understood nowadays therapeutic options are limited. The uremic syndrome is to be avoided by renal replacement therapy.

Entities:  

Keywords:  Diabetic nephropathy; Hyperphosphatemia; Hypertension; Hypertrophy, left ventricular; Renal replacement therapy

Mesh:

Year:  2017        PMID: 28194476     DOI: 10.1007/s00108-017-0195-2

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  29 in total

Review 1.  Smoking: a risk factor for progression of chronic kidney disease and for cardiovascular morbidity and mortality in renal patients--absence of evidence or evidence of absence?

Authors:  Stephan R Orth; Stein I Hallan
Journal:  Clin J Am Soc Nephrol       Date:  2007-11-14       Impact factor: 8.237

Review 2.  Peritoneal Dialysis in Western Countries.

Authors:  Dirk G Struijk
Journal:  Kidney Dis (Basel)       Date:  2015-09-03

3.  Effects of intensive blood-pressure control in type 2 diabetes mellitus.

Authors:  William C Cushman; Gregory W Evans; Robert P Byington; David C Goff; Richard H Grimm; Jeffrey A Cutler; Denise G Simons-Morton; Jan N Basile; Marshall A Corson; Jeffrey L Probstfield; Lois Katz; Kevin A Peterson; William T Friedewald; John B Buse; J Thomas Bigger; Hertzel C Gerstein; Faramarz Ismail-Beigi
Journal:  N Engl J Med       Date:  2010-03-14       Impact factor: 91.245

4.  Estimating glomerular filtration rate from serum creatinine and cystatin C.

Authors:  Lesley A Inker; Christopher H Schmid; Hocine Tighiouart; John H Eckfeldt; Harold I Feldman; Tom Greene; John W Kusek; Jane Manzi; Frederick Van Lente; Yaping Lucy Zhang; Josef Coresh; Andrew S Levey
Journal:  N Engl J Med       Date:  2012-07-05       Impact factor: 91.245

5.  A 12-week, double-blind, placebo-controlled trial of ferric citrate for the treatment of iron deficiency anemia and reduction of serum phosphate in patients with CKD Stages 3-5.

Authors:  Geoffrey A Block; Steven Fishbane; Mariano Rodriguez; Gerard Smits; Shay Shemesh; Pablo E Pergola; Myles Wolf; Glenn M Chertow
Journal:  Am J Kidney Dis       Date:  2014-11-04       Impact factor: 8.860

6.  Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial.

Authors:  Areef Ishani; Greg A Grandits; Richard H Grimm; Kenneth H Svendsen; Allan J Collins; Ronald J Prineas; James D Neaton
Journal:  J Am Soc Nephrol       Date:  2006-04-12       Impact factor: 10.121

Review 7.  Vascular calcification mechanisms.

Authors:  Cecilia M Giachelli
Journal:  J Am Soc Nephrol       Date:  2004-12       Impact factor: 10.121

8.  Bicarbonate supplementation slows progression of CKD and improves nutritional status.

Authors:  Ione de Brito-Ashurst; Mira Varagunam; Martin J Raftery; Muhammad M Yaqoob
Journal:  J Am Soc Nephrol       Date:  2009-07-16       Impact factor: 10.121

9.  A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.

Authors:  Marc A Pfeffer; Emmanuel A Burdmann; Chao-Yin Chen; Mark E Cooper; Dick de Zeeuw; Kai-Uwe Eckardt; Jan M Feyzi; Peter Ivanovich; Reshma Kewalramani; Andrew S Levey; Eldrin F Lewis; Janet B McGill; John J V McMurray; Patrick Parfrey; Hans-Henrik Parving; Giuseppe Remuzzi; Ajay K Singh; Scott D Solomon; Robert Toto
Journal:  N Engl J Med       Date:  2009-10-30       Impact factor: 91.245

Review 10.  Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis.

Authors:  Xinfang Xie; Emily Atkins; Jicheng Lv; Alexander Bennett; Bruce Neal; Toshiharu Ninomiya; Mark Woodward; Stephen MacMahon; Fiona Turnbull; Graham S Hillis; John Chalmers; Jonathan Mant; Abdul Salam; Kazem Rahimi; Vlado Perkovic; Anthony Rodgers
Journal:  Lancet       Date:  2015-11-07       Impact factor: 79.321

View more
  4 in total

Review 1.  Dysbiosis of the Human Urinary Microbiome and its Association to Diseases Affecting the Urinary System.

Authors:  Shehani Jayalath; Dhammika Magana-Arachchi
Journal:  Indian J Microbiol       Date:  2021-11-16       Impact factor: 2.461

2.  Effects of High-Flux Dialysis Combined with Hemoperfusion on Serum GRP78 and miR-495-3p in Renal Failure Patients.

Authors:  Wei Fan; Xudong Li; Xiangjun Xu; Hong Chu
Journal:  Biomed Res Int       Date:  2021-10-11       Impact factor: 3.411

3.  Application of B-ultrasound information image in Renal Puncture Biopsy treatment and Nursing.

Authors:  Linyan Dong; Junhong Li; Mixia Zhao; Jing Ren
Journal:  Pak J Med Sci       Date:  2021       Impact factor: 1.088

Review 4.  The roles of hydrogen sulfide in renal physiology and disease states.

Authors:  Jianan Feng; Xiangxue Lu; Han Li; Shixiang Wang
Journal:  Ren Fail       Date:  2022-12       Impact factor: 3.222

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.